The deal size was increased to $319M from $300M and priced below last closing price of $30.52. JPMorgan, Morgan Stanley, Jefferies and Evercore ISI are acting as joint book running managers for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AKRO:
- Akero Therapeutics announces $300M common stock offering
- Akero Therapeutics Announces Proposed Public Offering of Common Stock
- Akero Therapeutics price target raised to $50 from $35 at Jefferies
- Akero Therapeutics price target raised to $50 from $36 at Evercore ISI
- Akero upside capped on bone mineral density questions, says Cantor
